1. 2016 Wilson Sonsini Conference
    (Non-equity corporate financing options increase)

  2. 2016 Roth Capital Conference
    (Microcap companies enjoy macro attention of meeting attendees - Iradimed, Viewray)

  3. 2014 Canaccord Genuity Conference
    (EKSO and EVAR spark interest at conference)

  4. 2014 J.P. Morgan Healthcare Conference
    (AngioScore and Topera)

  5. 2013 Canaccord Genuity Conference
    (Newer med-tech companies enjoying continued progress)

  6. 2013 Wilson Sonsini Conference
    (Fund raising remains the key theme)

  7. 2013 J.P. Morgan Healthcare Conference
    (Private ophthalmic companies make their pitches to receptive audience)

  8. 2012 Canaccord Genuity Conference
    (Update on the aesthetics companies Solta, Zeltiq, Palomar and Syneron)

  9. 2012 Wilson Sonsini Conference
    (Focus on capital investment)

  10. 2012 J.P. Morgan Healthcare Conference
    (Bausch + Lomb, TriVascular, Penumbra and Optovue)


Atrial Fibrillation and Thoracic Surgery        

  1. 2015 Heart Rhythm Society
    (Balloon-based AF catheter ablation technologies show excellent results)

  2. 2012 Heart Rhythm Society
    (Topera’s mapping technology data shows great promise, may silence skeptics)

Interventional Cardiology

  1. 2013 TCT
    (Update on the renal denervation market)

  2. 2013 American College of Cardiology
    (Chaos surrounds release of PREVAIL Clinical Trial Data)

  3. 2013 American College of Cardiology
    (Discussion of Renal Denervation market)

  4. 2012 TCT
    (PFO clinical trials result in more questions than answers)

Interventional Radiology

  1. 2013 Society of Interventional Radiology
    (Prostate artery embolization [PAE] and irreversible electropoation [IRE])

  2. 2012 Society of Interventional Radiology
    (New innovative procedures showing promise - MS, IRE and BPH)


  1. 2016 American Academy of Ophthalmology
    (Glaucoma and corneal inlays key topics at AAO 2016)

  2. 2016 Cataract surgery developments
    (Startup company develops innovative cataract surgery device)

  3. 2016 360-New Horizons Glaucoma Forum
    (Glaucoma Research Foundation 2016 “New Horizons” Meeting)

  4. 2015 American Academy of Ophthalmology
    (Glaucoma technology update, with comments on MIGS and Iridex)

  5. 2015 American Society of Cataract and Refractive Surgery
    (Companies show innovation can still be focus for the ophthalmology sector)

  6. 2015 360-New Horizons Glaucoma Forum
    (Catalyst for a Cure and MIGS devices featured at conference)

  7. 2014 Ophthalmology Innovation Summit
    (Innovative ophthalmology companies discuss recent successes)

  8. 2014 American Academy of Ophthalmology
    (Jeff George, Global Head of Alcon, discusses “Accelerating Innovation in Ophthalmology”)

  9. 2014 American Society of Cataract and Refractive Surgery
    (Revolutionary LAL shows tremendous promise for cataract surgery)

  10. 2014 New Horizons Glaucoma Forum
    (Personalized glaucoma management using IOP monitors, update on MIGS companies)

  11. 2013 American Academy of Ophthalmology
    (Several companies prospering in upbeat ophthalmology market)

  12. 2013 Ophthalmology Innovation Summit at ASCRS
    (Renowned VC discusses future prospects for ophthalmic surgery innovation)

  13. 2013 New Horizons Glaucoma Forum
    (MIGS ‘new sexy’ in glaucoma device world)

  14. 2012 Ophthalmology Innovation Summit at AAO
    (Treatment of AMD and corneal problems)

  15. 2012 Ophthalmology Innovation Summit at ASCRS
    (Conference’s ‘vision’ allows industry leaders second sight)

  16. 2012 New Horizons Glaucoma Forum
    (New real-time IOP measurement and drug delivery devices)


  1. 2016 International Stroke Conference
    (Thrombectomy devices making a major impact on the acute ischemic stroke market)

  2. 2014 International Stroke Conference
    (Ischemic stroke devices offer hope amidst more failed clinical trials)

  3. 2013 International Stroke Conference
    (Update on ischemic stroke trials)

Vascular Surgery

  1. 2016 Vascular Interventional Advances (VIVA) Conference
    (Drug-coated balloons, Shockwave Medical and TVA Medical in the spotlight)

  2. 2014 Vascular Interventional Advances (VIVA) Conference
    (Physician interest in drug-coated balloons continues to increase)

  3. 2013 Vascular Interventional Advances (VIVA) Conference
    (EVAR market showing strong growth; new entrants enliven the competitive landscape)


  1. Interview with Larry Haimovitch from Medical Product Outsourcing Magazine
    April 2010: “Cardio’s ‘Next Big Thing’”

  2. Interview with Larry Haimovitch from Biomedical Business & Technology
    November 2009

ARCHIVES (2008 - 2011)

  1. “Word on the Street” March 2011

  2. (A discussion of earnouts arising from acquisitions)

  3. “Word on the Street” January 2011

  4. (Compares private and public company performances)

  5. 2011 International Stroke Conference 2
    (Acute ischemic stroke market: Concentric, Penumbra, Reverse Medical, Insera Therapeutics)

  6. 2011 International Stroke Conference 1
    (Carotid artery intervention: stenting vs. endarterectomy debate continues)

  7. 2011 American Society of Cataract and Refractive Surgery
    (Red hot interest in femtosecond laser-assisted cataract surgery)

  8. 2011 Heart Rhythm Society 1
    (AFib update, Topera Medical)

  9. 2011 Heart Rhythm Society 2
    (CardioFocus and Endosense)

  10. 2011 Society of Thoracic Surgeons Annual Meeting
    (Left atrial appendage closure, Atricure)

  11. 2011 Canaccord Genuity Conference
    (Syneron, Solta, Ulthera and Cutera)

  12. 2011 Wells Fargo Securities Conference
    (Symetis, Direct Flow Medical, PowerVision and Arstasis )

  13. 2011 Wilson Sonsini Conference
    (VC and FDA regulations)

  14. 2011 J.P. Morgan Healthcare Conference
    (Zeltiq Aesthetics, TriVascular and Penumbra)

  15. “Word on the Street” November 2010
    (Sadra and Ardian acquisitions, Endologix purchase of Nellix)

  16. 2010 International Stroke Conference 1
    (Acute ischemic stroke therapy, Penumbra)

  17. 2010 International Stroke Conference 2
    (CREST - Endarterectomy vs. stenting trial)

  18. 2010 Second Annual Ophthalmology Innovation Summit
    (Review of several presenting companies and panels)

  19. 2010 American Academy of Ophthalmology Meeting
    (STAAR Surgical analyst meeting, femtosecond lasers for cataract surgery)

  20. 2010 American Society of Cataract and Refractive Surgery 1
    (STAAR Surgical analyst meeting)

  21. 2010 American Society of Cataract and Refractive Surgery 2
    (Femtosecond lasers for cataract surgery, LenSx)

  22. 2010 Heart Rhythm Society
    (CryoCath/Medtronic, Stereotaxis, Endosense)

  23. 2010 Boston Atrial Fibrillation Symposium
    (CardioFocus, Endosense)

  24. 2010 Piper Jaffray Health Care Conference
    (Barrx, superDimension)

  25. 2010 Canaccord Genuity Global Growth Conference
    (Vascular Solutions and Lemaitre Vascular)

  26. 2010 Wilson Sonsini Conference
    (European commercialization and reimbursement strategies)

  27. 2010 Canaccord Genuity Cardiovascular and Diabetes Conference
    (Access Closure and Arstasis) 

  28. 2010 J.P. Morgan Healthcare Conference

  29. 2010 OneMedPlace Conference
    (Various private ophthalmic companies)

  30. 2009 American Urological Association
    (Prostate cancer therapy, Accuray)

  31. 2009 Canaccord Adams Cardiovascular Conference 1
    (AAA stent graft market, Endologix, Nellix and Lemaitre Vascular)

  32. 2009 Canaccord Adams Cardiovascular Conference 2
    (CardioFocus, Estech, Endosense)

  33. 2009 Wilson Sonsini Conference
    (Venture capital returns and outlook)

  34. 2009 Heart Rhythm Society
    (AFib catheter ablation, CardioFocus)

  35. 2009 Scripps Clinic AFib Conference
    (AFib acquisitions, Endosense and CardioFocus)

  36. 2009 First Annual Ophthalmology Innovation Summit
    (Review of several presenting companies and panels)

  37. 2009 Hawaiian Eye Meeting
    (Macular degeneration, presbyopic IOLs)

  38. 2009 American Society of Cataract and Refractive Surgery
    (Femtosecond lasers for cataract surgery, LenSx, Optimedica, LensAR, glaucoma)

  39. 2009 American Academy of Ophthalmology Meeting
    (Alcon, STAAR Surgical, NeoVista, Oraya Therapeutics)

  40. 2009 International Stroke Conference
    (Photothera, CoAxia, Brainsgate, Penumbra)

  41. 2008 Boston Atrial Fibrillation Symposium

  42. 2008 Canaccord Adams Global Growth Conference

  43. 2008 American Urological Association Annual Meeting

  44. 2008 Heart Rhythm Society
    (Pulmonary vein isolation for AFib, Atricure)

Recent Articles

About HMTCabout.htmlabout.htmlshapeimage_9_link_0

“Larry is an outstanding medical device consultant, advisor and investor. He
has a sharp, strategic and thoughtful mind. I have heard from several executives that Larry provides outstanding counsel. Most importantly, he has become a good friend.”

    Jason Mills

    Medical Device Analyst

    and Managing Director

    CanAccord Adams